Masaaki Tomoi

867 total citations
39 papers, 764 citations indexed

About

Masaaki Tomoi is a scholar working on Molecular Biology, Surgery and Cellular and Molecular Neuroscience. According to data from OpenAlex, Masaaki Tomoi has authored 39 papers receiving a total of 764 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 7 papers in Surgery and 7 papers in Cellular and Molecular Neuroscience. Recurrent topics in Masaaki Tomoi's work include Synthesis and biological activity (5 papers), Neuropeptides and Animal Physiology (5 papers) and Receptor Mechanisms and Signaling (5 papers). Masaaki Tomoi is often cited by papers focused on Synthesis and biological activity (5 papers), Neuropeptides and Animal Physiology (5 papers) and Receptor Mechanisms and Signaling (5 papers). Masaaki Tomoi collaborates with scholars based in Japan and United States. Masaaki Tomoi's co-authors include Makoto Kadowaki, Kyoichi Shimomura, Hisashi Takasugi, Yoshikazu Inoue, S Nishino, Jo Mori, Kenichi Tokita, MASANOBU KOHSAKA, Ikuo Kawamura and Norio Ishida and has published in prestigious journals such as FEBS Letters, Journal of Medicinal Chemistry and Journal of Neurochemistry.

In The Last Decade

Masaaki Tomoi

38 papers receiving 716 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Masaaki Tomoi Japan 16 283 162 145 125 118 39 764
R.M. Gaion Italy 17 247 0.9× 149 0.9× 56 0.4× 100 0.8× 50 0.4× 58 715
R. Micheletti Italy 22 1.1k 4.0× 163 1.0× 101 0.7× 102 0.8× 536 4.5× 52 1.6k
Koji Ueshima Japan 15 281 1.0× 180 1.1× 275 1.9× 54 0.4× 247 2.1× 43 907
Katsuichi Shuto Japan 12 246 0.9× 119 0.7× 52 0.4× 128 1.0× 100 0.8× 88 639
David J Hele United Kingdom 17 258 0.9× 343 2.1× 131 0.9× 25 0.2× 89 0.8× 24 947
Diane M. Hargrove United States 17 346 1.2× 157 1.0× 169 1.2× 61 0.5× 81 0.7× 29 792
P. S. Schönhöfer Germany 14 214 0.8× 157 1.0× 76 0.5× 24 0.2× 80 0.7× 39 564
Hideki Ukawa Japan 12 132 0.5× 169 1.0× 254 1.8× 30 0.2× 88 0.7× 18 631
M J Daly United Kingdom 14 209 0.7× 103 0.6× 75 0.5× 23 0.2× 116 1.0× 30 524
Yusaku Komoike Japan 15 93 0.3× 70 0.4× 225 1.6× 40 0.3× 64 0.5× 21 579

Countries citing papers authored by Masaaki Tomoi

Since Specialization
Citations

This map shows the geographic impact of Masaaki Tomoi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masaaki Tomoi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masaaki Tomoi more than expected).

Fields of papers citing papers by Masaaki Tomoi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Masaaki Tomoi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masaaki Tomoi. The network helps show where Masaaki Tomoi may publish in the future.

Co-authorship network of co-authors of Masaaki Tomoi

This figure shows the co-authorship network connecting the top 25 collaborators of Masaaki Tomoi. A scholar is included among the top collaborators of Masaaki Tomoi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Masaaki Tomoi. Masaaki Tomoi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kadowaki, Makoto, et al.. (2002). Adenosine A1 receptor blockade reverses experimental postoperative ileus in rat colon. European Journal of Pharmacology. 458(1-2). 197–200. 25 indexed citations
2.
Kawamura, Ikuo, Ryuichi Morishita, Naohiro Tomita, et al.. (1999). Intratumoral injection of oligonucleotides to the NFκB binding site inhibits cachexia in a mouse tumor model. Gene Therapy. 6(1). 91–97. 102 indexed citations
3.
Ishikawa, H., Yoshimi Matsumoto, Toshiaki Kamimura, et al.. (1999). FR145715, a novel histamine H2 receptor antagonist, with specific anti-Helicobacter pylori activities. European Journal of Pharmacology. 378(3). 299–310. 6 indexed citations
4.
Yamamoto, Hiroko, Shoji Takakura, Tadashi Yamamoto, et al.. (1997). FR149175, a .BETA.3-Adrenoceptor-Selective Agonist, Is a Possible Therapeutic Agent for Non-Insulin-Dependent Diabetes Mellitus.. The Japanese Journal of Pharmacology. 74(1). 109–112. 15 indexed citations
5.
Tomoi, Masaaki, et al.. (1996). Implication of Sensory Neurons in the Diverse Mechanisms of Adaptive Cytoprotection in the Rat Stomach. The Japanese Journal of Pharmacology. 70(4). 347–350. 4 indexed citations
6.
Matsuo, Masahiko, et al.. (1996). Difference between Normal and WHHL Rabbits in Susceptibility to the Adrenal Toxicity of an Acyl-CoA:Cholesterol Acyltransferase Inhibitor, FR145237. Toxicology and Applied Pharmacology. 140(2). 387–392. 30 indexed citations
7.
Nagano, Masanobu, et al.. (1994). Synthesis and Anticholinergic Activity of the Four Stereoisomers of 4-(Dimethylamino)-2-phenyl-2-(2-pyridyl)pentanamide. Journal of Medicinal Chemistry. 37(9). 1378–1381. 8 indexed citations
8.
Kadowaki, Makoto, Yukinori Nagakura, Masaaki Tomoi, Jo Mori, & MASANOBU KOHSAKA. (1993). Effect of FK1052, a potent 5-hydroxytryptamine3 and 5-hydroxytryptamine4 receptor dual antagonist, on colonic function in vivo.. Journal of Pharmacology and Experimental Therapeutics. 266(1). 74–80. 58 indexed citations
9.
Matsuo, Masahiko, et al.. (1993). Multiple Mediators and Mechanisms Are Involved in the Adaptive Cytoprotection Provided by Certain Mild Irritants. The Japanese Journal of Pharmacology. 63(2). 251–256. 11 indexed citations
10.
Tomoi, Masaaki, et al.. (1992). Studies on Antiulcer Drugs. V. Synthesis and Antiulcer Activity of Aralkylbenzazoles.. Chemical and Pharmaceutical Bulletin. 40(8). 2062–2074. 4 indexed citations
11.
Kadowaki, Makoto, et al.. (1992). FK480: a novel CCK-A receptor antagonist. The Japanese Journal of Pharmacology. 58. 130–130. 3 indexed citations
12.
Inoue, Yoshikazu, et al.. (1992). Studies on Antiulcer Drugs. IV. Synthesis and Antiulcer Activities of Imidazo(1,2-a)pyridinylethylbenzothiazoles and -benzimidazoles.. Chemical and Pharmaceutical Bulletin. 40(7). 1818–1822. 11 indexed citations
14.
Kanda, Tatsuo, Shoji Odani, Masaaki Tomoi, Yoichi Matsubara, & Teruo Ono. (1991). Primary structure of a 15‐kDa protein from rat intestinal epithelium. European Journal of Biochemistry. 197(3). 759–769. 26 indexed citations
15.
Tomoi, Masaaki, et al.. (1990). Modulation of 3H-prostaglandin E2 binding sites in the rabbit gastric mucosa. Prostaglandins. 39(2). 113–122. 3 indexed citations
16.
Yamada, Hisashi, et al.. (1989). High‐Level Expression and Efficient Purification of Recombinant Somatostatin in Escherichia Coli. Biotechnology Progress. 5(1). 40–45. 4 indexed citations
17.
Ishida, Norio, et al.. (1989). Differential activities of two distinct endothelin family peptides on ileum and coronary artery. FEBS Letters. 247(2). 337–340. 70 indexed citations
18.
Tomoi, Masaaki, et al.. (1988). Effects of omeprazole and famotidine on (H+-K+) ATPase and acid secretion in rabbit gastric glands.. Folia Pharmacologica Japonica. 92(2). 105–111. 5 indexed citations
19.
Nakao, Yasuhiko, et al.. (1986). [Case report of familial juvenile polyposis of the stomach associated with gastrointestinal malignancy].. PubMed. 83(7). 1376–81. 2 indexed citations
20.
Iwata, Hisato, et al.. (1971). ENHANCEMENT OF BRAIN THIAMINE DIPHOSPHATASE ACTIVITY OF RATS BY INJECTION OF CHOLINERGIC DRUGS. Journal of Neurochemistry. 18(8). 1371–1377. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026